News > Bharat Biotech ends its Brazil agreement. What went wrong?

Bharat Biotech ends its Brazil agreement. What went wrong?

Bharat Biotech on Friday announced the termination its agreement with two foreign firms for the supply of COVAXIN to Brazil. Following that, Brazil canceled the proposed clinical trails of the vaccine in that country.

These are the latest developments in a series of reactions after the Brazilian government suspended the $324 million deal with the Indian firm amid corruption allegations. What exactly went wrong? What was the deal all about?